Journal article icon

Journal article

Hydroxychloroquine retinopathy.

Abstract:

Hydroxychloroquine (HCQ; Plaquenil) is used increasingly in the management of a variety of autoimmune disorders, with well established roles in dermatology and rheumatology and emerging roles in oncology. Hydroxychloroquine has demonstrated a survival benefit in patients with systemic lupus erythematosus; some clinicians advocate its use in all such patients. However Hydroxychloroquine and chloroquine (CQ) have been associated with irreversible visual loss due to retinal toxicity. Hydroxychlo...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1038/eye.2016.298

Authors


More by this author
Institution:
University of Oxford
Oxford college:
Merton College
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Clinical Neurosciences
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDORMS
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Clinical Neurosciences
Role:
Author
Publisher:
Nature Publishing Group Publisher's website
Journal:
Eye Journal website
Volume:
31
Issue:
6
Pages:
828-845
Publication date:
2017-03-01
Acceptance date:
2016-08-24
DOI:
EISSN:
1476-5454
ISSN:
0950-222X
Source identifiers:
685370
Language:
English
Keywords:
Pubs id:
pubs:685370
UUID:
uuid:4ffa9df5-3f98-48d3-9dc4-d895deb29d7f
Local pid:
pubs:685370
Deposit date:
2017-08-14

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP